- Home
- GOEV vs RPID Comparison
GOEV vs RPID Comparison
Compare GOEV & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOEV
- RPID
- Stock Information
- Founded
- GOEV 2017
- RPID 2006
- Country
- GOEV United States
- RPID United States
- Employees
- GOEV N/A
- RPID N/A
- Industry
- GOEV
- RPID Medical Specialities
- Sector
- GOEV
- RPID Health Care
- Exchange
- GOEV Nasdaq
- RPID Nasdaq
- Market Cap
- GOEV 34.3M
- RPID 37.3M
- IPO Year
- GOEV N/A
- RPID 2021
- Fundamental
- Price
- GOEV $0.50
- RPID $1.04
- Analyst Decision
- GOEV Strong Buy
- RPID
- Analyst Count
- GOEV 6
- RPID 0
- Target Price
- GOEV $22.71
- RPID N/A
- AVG Volume (30 Days)
- GOEV 8.8M
- RPID 128.8K
- Earning Date
- GOEV 11-13-2024
- RPID 11-01-2024
- Dividend Yield
- GOEV N/A
- RPID N/A
- EPS Growth
- GOEV N/A
- RPID N/A
- EPS
- GOEV N/A
- RPID N/A
- Revenue
- GOEV $1,864,000.00
- RPID $26,170,000.00
- Revenue This Year
- GOEV $2,999.89
- RPID $24.34
- Revenue Next Year
- GOEV $1,016.40
- RPID $19.49
- P/E Ratio
- GOEV N/A
- RPID N/A
- Revenue Growth
- GOEV 259.15
- RPID 27.31
- 52 Week Low
- GOEV $0.37
- RPID $0.58
- 52 Week High
- GOEV $8.81
- RPID $1.34
- Technical
- Relative Strength Index (RSI)
- GOEV 36.38
- RPID 48.03
- Support Level
- GOEV $0.48
- RPID $1.16
- Resistance Level
- GOEV $0.76
- RPID $1.30
- Average True Range (ATR)
- GOEV 0.11
- RPID 0.11
- MACD
- GOEV 0.01
- RPID -0.01
- Stochastic Oscillator
- GOEV 24.32
- RPID 3.23
About GOEV Canoo Inc.
Canoo Inc is a mobility technology company providing with a proprietary modular electric vehicle platform and connected services initially focused on commercial fleet, government and military customers. The Company has developed a breakthrough EV platform that it believes will enable it to rapidly iterate and bring new products, addressing multiple use cases, to market faster than competition and at lower cost.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.